News Releases Items per page 102550 Date Title View Toggle SummaryOctober 26, 2009 Biocentury - RhoKing Glaucoma View HTML Toggle SummaryOctober 22, 2009 Aerie Pharmaceuticals’ ROCK Inhibitor, AR-12286, Demonstrates Positive Results in Glaucoma Patients in a Phase 2a Study Novel Drug has Potential to Create Significant Improvement in Function of Diseased Tissue View HTML Aerie Pharmaceuticals’ ROCK Inhibitor, AR-12286, Demonstrates Positive Results in Glaucoma Patients in a Phase 2a Study 22 KB Pagination First page First Previous page Previous … Page 27 Page 28 Page 29 Current page 30
Aerie Pharmaceuticals’ ROCK Inhibitor, AR-12286, Demonstrates Positive Results in Glaucoma Patients in a Phase 2a Study 22 KB
